Clinical Significance Of Lipoproteins Flashcards
Framingham heart study
Monitors the development and progression of cardiovascular disease over three generations
- revealed major CVD risk factors to be the following
1) increased blood pressure
2) increased blood triglyceride levels
3) increased cholesterol leaves
4) decreased high density lipoproteins
5) increased low density lipoproteins - first study to demonstrate an inverse relationship between HDL concentrations and chances of having coronary heart disease (CHD)
- patients that have low LDL and low HDL have almost as high of a chance of getting CHD as patients with high LDL and low HDL*
Framingham heart study specific statistics
1) suggest that the prevalence of CHD increases by 25-30% every 10mg decrease in HDL
2) more than 50% chance of having CHD in patients with <45mg of HDL
3) patients who have low LDL levels (<100mg) still have an increased risk of CHD and atherosclerosis if HDL levels drop
How do cells respond to a drop in intracellular concentration of cholesterol?
1) making new cholesterol via de novo synthesis from acetyl-CoA
2) import cholesterol from LDL in the blood via endo cytosol using LDL receptors
What gene regulates LDL uptake?
Sterol regulatory element-1 gene (SRE-1)
- more active = increased LDL removed from blood and excreted via liver metabolism- reduces CHD risk
Cholesterol uptake vs synthesis
Cholesterol uptake is regulated via controlling the rate of SLE-1 gene action and the reduction of HMG-CoA reductase via allosteric inhibition
- inhibiting HMG-CoA is when intracellular cholesterol levels are high only
- increasing SLE-1 gene activity is when the intracellular cholesterol levels are low
Steps in receptor mediated endocytosis of LDL
1) LDL receptors found in clathrate-coated pits on cell surfaces bind to LDL molecules via apoprotein B-100 in th eLDL
2) once bound LDL-B-100 complex is endocytosed
3) forms vesicles called endoscope sin cells
4) pH of the endoscope falls which allows separation of LDL from the receptor, allowing the receptor to bind more LDL (whereas the previously bound LDL remains in the endoscope)
5) LDLs in endoscope are degraded via lysosomes, and receptors can be recycled if needed
Familial hypercholesterolemia
Genetic disorder characterized by a wide variety of mutation on the LDL receptor gene (primarily the PCSK9 mutation or app B-100 gene)
- all mutations present proper binding of LDL to the LDL receptor, allowing for a lot of excess LDL floating in the blood.
Heterozygous FH = 1:500
- treated via statins and PCSK9 inhibits, doesn’t usually kill
Homozygous FH = 1:1,000,000
- often kills and does not respond to drug therapy
- needs LDL apheresis and liver transplantation as modes of treatment
Drugs that increase HDL-cholesterol
PPAR-alpha activators (fish oils/ fibrates)
Niacin
CETP inhibitors
Drugs that lower LDL-cholesterol
STATINs
Cholesterol absorption inhibitors (ezetimibe)
Bile acid binding resins
(Colestipol, cholestyramine)
PCSK9 inhibitors
( Praluent and repatha)
STATINs MOA
Statins act as competitive inhibitors for HMG-CoA reductase enzyme, inhibiting it
- this prevents cholesterol synthesis in the liver.
- significant since most LDL circulating in the blood is synthesized rather than taken in by dietary means
Also work to increase activation of SRE-1 gene which increases LDL receptor production
HMG-CoA reductase is the rate-limiting enzyme in cholesterol biosynthesis
Pleiotropic effects of statins
Pleiotropic = additional effects on other systems that may or may not be beneficial
- in this case all are good
Improve endothelial function
Enhance plaque stability (prevent thrombosis)
Decrease oxidative stress, inflammation, thrombogenic response
Beneficial effects on immune system, CNS, and bone
ADRs of statins
Muscle/joint pain ( most common side effect but only 10% occurrence)
Rhabdomyolysis (1:10,000)
Mind/memory issues (this is not 100% proven)
Increases blood sugars (bad for diabetics)
- Cana Leo slightly increase chances of type 2 diabetes
May or may not cause liver damage
What statins have the longes half life?
Rosuvastatin (Crestor)
- t1/2 = 19hrs
- most efficacious
atorvastatin (Lipitor)
- t1/2 = 14hrs
- 2nd most efficacious
- less ADRs than rosuvastatin
- most profitable drug in the history of pharm
- these dont have to be taken at night*
What statins have the shortest life?
Simvastatin
- t1/2 = 2hrs
Pravastatin
- t1/2 = 2hrs
Lovastatin
- t1/2 = 2hrs
Fluvastatin
- t1/2 = 1 hr
- all need to be taken at night only*
Affects of Ezetimibe
Blocks uptake of dietary cholesterol in the intestines via blocking the NPC1L-1 protein receptor
- causes this cholesterol to be excreted and forces the liver to absorb more cholesterol from the blood stream, hence lowering VDL in the blood stream
- MOST commonly 2nd added statin*
- only time monotherapy is recommended is patients who have primary hypercholesterolemia and cant tolerate statins